SMTL ID : 8gk5.2 (3 other biounits)

EGFR(T790M/V948R) kinase in complex with osimertinib and benzimidazole allosteric inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x Q6K: ~{N}-[2-[2-(dimethylamino)ethyl-methyl-amino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]propanamide(Covalent)

Q6K.1: 19 residues within 4Å: Chain A: L.27, G.28, S.29, V.35, A.52, M.99, Q.100, L.101, M.102, P.103, F.104, G.105, C.106, D.109, E.113, R.150, L.153, D.164 Ligands: YW5.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.35, A:V.35, A:A.52, A:L.153 Hydrogen bonds: A:M.102, A:M.102, A:G.105, A:C.106, A:D.109 Salt bridges: A:E.113

1 x YW5: 2-[(R)-(1H-benzimidazol-2-yl)(3-fluorophenyl)methyl]-6-[4-(1-methylpiperidin-4-yl)phenyl]-2,3-dihydro-1H-isoindol-1-one(Non-covalent)

YW5.2: 21 residues within 4Å: Chain A: A.31, F.32, V.35, A.52, I.53, K.54, L.56, E.67, I.68, M.75, C.84, R.85, L.86, L.97, I.98, M.99, T.163, D.164, F.165, L.167 Ligands: Q6K.1 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.32, A:V.35, A:V.35, A:A.52, A:K.54, A:L.56, A:I.68, A:I.68, A:L.97, A:L.97, A:F.165, A:L.167 Salt bridges: A:E.67 pi-Stacking: A:F.32

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Beyett, T.S. et al., Development of benzimidazole allosteric EGFR kinase inhibitors. To be published

Release Date

2024-06-26

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Epidermal growth factor receptor

Related Entries With Identical Sequence